Philogen S.p.A. (PHIL.MI)
EUR 21.7
(-0.46%)
EUR 21.7
(-0.46%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.92 Million EUR | -82.52% |
| 2022 | 11.02 Million EUR | -0.71% |
| 2021 | 11.09 Million EUR | -1.52% |
| 2020 | 11.27 Million EUR | 1552.49% |
| 2019 | 682 Thousand EUR | -87.82% |
| 2018 | 5.6 Million EUR | -12.03% |
| 2017 | 6.36 Million EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 Q1 | 13.42 Million EUR | 21.81% |
| 2023 FY | 1.92 Million EUR | -82.52% |
| 2023 Q3 | 13.02 Million EUR | 17.63% |
| 2023 Q2 | 11.07 Million EUR | -17.51% |
| 2023 Q4 | 1.92 Million EUR | -85.21% |
| 2022 Q3 | 14 Million EUR | 24.37% |
| 2022 FY | 11.02 Million EUR | -0.71% |
| 2022 Q2 | 11.26 Million EUR | -22.71% |
| 2022 Q1 | 14.57 Million EUR | 31.28% |
| 2022 Q4 | 11.02 Million EUR | -21.33% |
| 2021 FY | 11.09 Million EUR | -1.52% |
| 2021 Q4 | 11.09 Million EUR | -24.42% |
| 2021 Q3 | 14.68 Million EUR | 31.97% |
| 2021 Q2 | 11.12 Million EUR | -26.46% |
| 2021 Q1 | 15.13 Million EUR | 34.27% |
| 2020 Q1 | - EUR | -100.0% |
| 2020 FY | 11.27 Million EUR | 1552.49% |
| 2020 Q4 | 11.27 Million EUR | 0.0% |
| 2019 FY | 682 Thousand EUR | -87.82% |
| 2019 Q4 | 12.64 Million EUR | 0.0% |
| 2018 FY | 5.6 Million EUR | -12.03% |
| 2017 FY | 6.36 Million EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| ARTERRA BIOSCIENCE | 299.76 Thousand EUR | -542.499% |
| Ulisse Biomed S.p.A. | 414.99 Thousand EUR | -364.105% |